According to Samsung Biologics 's latest financial reports the company's current EPS (TTM) is $8.94. In 2022 the company made an earnings per share (EPS) of $8.94 an increase over its 2021 EPS that were of $5.07.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $8.94 | 0.06% |
2022 | $8.94 | 76.23% |
2021 | $5.07 | 61.48% |
2020 | $3.14 | 21.05% |
2019 | $2.59 | -12.56% |
2018 | $2.97 | -330.46% |
2017 | -$1.29 | -51.86% |
2016 | -$2.67 |